Recent Articles from GlobeNewswire
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
By Abivax · Via GlobeNewswire · July 2, 2026
SINGAPORE, July 02, 2026 (GLOBE NEWSWIRE) -- Qoder, the agentic coding platform, today introduced off-peak pricing for Qwen3.7-Max and Qwen3.7-Plus, the latest models in Qwen family. During off-peak hours, defined as 14:00 to 00:00 UTC daily, both models are billed at reduced Credits multipliers. During regular hours (00:00 to 14:00 UTC), Qwen3.7-Max is billed at a 0.25x Credits multiplier, half its standard 0.5x rate. The discount is applied automatically for all Pro Trial and paid users, with no opt-in or signup, and works across every Qoder product. Together, the two windows make Qoder the most cost-effective way to build with Qwen3.7-Max and Qwen3.7-Plus.
By Qoder · Via GlobeNewswire · July 2, 2026
ISS, a leading global workplace experience and facility services company, has extended and expanded its partnership with a public healthcare provider in Southern Europe. The expanded scope of the agreement has an annual value of approximately DKK 100 million.
By ISS World Services A/S · Via GlobeNewswire · July 2, 2026
LexisNexis Risk Solutions’ risk intelligence with Promon Shield in-app protection and Promon Insight trusted telemetry together aim to help organizations protect mobile apps from manipulation and enable more trusted fraud decisions
By Promon · Via GlobeNewswire · July 2, 2026
Issy-les-Moulineaux, July 2, 2026 (7:00 a.m. CEST)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)
By Sodexo SA · Via GlobeNewswire · July 2, 2026
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. and VILLEJUIF, France, July 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners”), and Orano Med, a clinical-stage radiopharmaceutical company and a pioneer in the development of lead-212 (212Pb) based targeted alpha therapies (TAT), today announced that the first patients were dosed in the ongoing US multicenter Phase 1/2a study of drug candidate MP0712.
By Molecular Partners · Via GlobeNewswire · July 2, 2026
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that it has entered into a definitive securities purchase agreement led by two new fundamental institutional investors with participation from a large existing shareholder for the purchase of an aggregate of 4,380,313 shares of its common stock pursuant to a registered direct offering (the “Offering”). The Offering is expected to result in gross proceeds of approximately $15 million, before deducting placement agents’ fees and other Offering expenses. The closing of the Offering is expected to occur on or about July 6, 2026, subject to the satisfaction of customary closing conditions. Elicio intends to use the net proceeds from the Offering, together with its existing cash, cash equivalents and marketable securities, to primarily fund the planned Phase 1 clinical development of ELI-002 7P in metastatic PDAC and Elicio’s pipeline and platform, as well as for working capital and general corporate purposes.
By Elicio Therapeutics Inc. · Via GlobeNewswire · July 2, 2026
Latest assays such as 42m @ 6.1% CuEq and 9.8m @ 16.5% CuEq, which demonstrate the outstanding continuity of the high-grade zone, will feed into the impending economic studies
By FireFly Metals Limited · Via GlobeNewswire · July 1, 2026
MELBOURNE, Australia and INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX, “Telix”) today announced the successful outcome of a Type B meeting with the United States (U.S.) Food and Drug Administration (FDA) to review the Part 1 safety and dosimetry data and Part 2 protocol design of the ProstACT Global Phase 3 trial of its therapeutic candidate TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in metastatic castration resistant prostate cancer.
By Telix Pharmaceuticals Limited · Via GlobeNewswire · July 1, 2026
Japan-Originated Global Biopharma Company Founded in 2001 Enters Its “Second Founding Phase”
By GNI Group Co., Ltd. · Via GlobeNewswire · July 1, 2026
Marsha Reyngold, M.D., Ph.D. v. National Institutes of Health, National Library of Medicine, Department of Health and Human Services
By New Civil Liberties Alliance · Via GlobeNewswire · July 1, 2026
SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the company has recently entered into a license agreement with Fosun Wanbang Pharma Group (“Fosun Wanbang,” a wholly-owned subsidiary of Fosun Pharma (HKEX: 02196; SSE: 600196). The two parties will cooperate on the development, registration, manufacturing and commercialization of roconkibart (JS005, anti-IL-17A monoclonal antibody) in the Greater China region, which includes the Chinese mainland, Hong Kong Special Administrative Region, Macao Special Administrative Region, and Taiwan.
By Junshi Biosciences · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Badger Meter, Inc. (“Badger Meter” or the “Company”) (NYSE:BMI) investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.
By Kirby McInerney LLP · Via GlobeNewswire · July 1, 2026
State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder
By FDA · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Meridian3 Industrials Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 17,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market, or Nasdaq, and trade under the ticker symbol “MIACU” with trading expected to begin on July 2, 2026. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “MIAC” and “MIACW,” respectively.
By MERIDIAN3 INDUSTRIALS ACQUISITION CORP · Via GlobeNewswire · July 1, 2026
Sworn Declarations from Former FDA Counsel and Renowned Device Regulation Expert Expose Clear Regulatory Carve-Outs for Outpatient Clinics; Emergency Motion Seeks to Strike Verdict Before July 7 Sentencing
By Doctor Sanjeev Kumar · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · July 1, 2026
PASADENA, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Wedbush today announced that Dan Ives, MD, Global Head of Technology Research, has departed the firm to establish a new investment banking venture.
By Wedbush · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).
By Guggenheim Partners Investment Management Holdings, LLC · Via GlobeNewswire · July 1, 2026
Recognition validates technical expertise in mission-critical environments and enables the company to deploy solutions built on Google's most advanced models
By AI/R Group US Holding Corp · Via GlobeNewswire · July 1, 2026
TORONTO, July 01, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that Abaxx Exchange surpassed 100,000 contracts traded in a single day on July 1, 2026, with total volume reaching 117,879 contracts.
By Abaxx Technologies Inc. · Via GlobeNewswire · July 1, 2026
Amendment Modernizes Commercial Terms, Lowers Future Subscriber Costs, and Strengthens the Company’s Balance Sheet
By SurgePays, Inc. · Via GlobeNewswire · July 1, 2026
BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Following its highly anticipated opening, The Atlas Hotel unveils the details of its highly curated art and design program. Developed by global real estate leader Tishman Speyer at the gateway of Harvard University’s Enterprise Research Campus, The Atlas’ art initiative goes beyond the city’s traditional hotel model. With its art program, The Atlas presents a collection of contemporary and emerging artists whose works are exhibited across premier galleries and art museums in New York, Boston, Los Angeles, and beyond.
By The Atlas Hotel · Via GlobeNewswire · July 1, 2026
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Phreesia (PHR) To Contact Them Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 1, 2026
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Black Rock (BRCB) To Contact Them Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 1, 2026
RENO, Nev., July 01, 2026 (GLOBE NEWSWIRE) -- Employers Holdings, Inc. (NYSE:EIG), today announced that on June 25, 2026, Stephanie C. Bush was elected to the Board of Directors, with her term of service commencing on July 1, 2026.
By Employers Holdings Inc · Via GlobeNewswire · July 1, 2026
HAMILTON, Bermuda, July 01, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty underwriter, has today announced the appointment of Mark Aspinall as Head of its new Fine Art & Specie team, effective January 2027.
By SiriusPoint Ltd. · Via GlobeNewswire · July 1, 2026
FRISCO, TX, July 01, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its second quarter 2026 results on July 29, 2026 after the market closes and host its quarterly conference call at 10:00 a.m. CT on July 30, 2026 to discuss the second quarter results.
By Comstock Resources, Inc. · Via GlobeNewswire · July 1, 2026
CALHOUN, Ga., July 01, 2026 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries’ (NYSE: MHK) Second Quarter 2026 earnings release on Thursday, July 30, 2026, you are invited to listen to the conference call that will be broadcast live on Friday, July 31, 2026, at 11:00 am ET.
By Mohawk Industries, Inc. · Via GlobeNewswire · July 1, 2026
HOUSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its second quarter 2026 financial results after close of market on Wednesday, August 5, 2026, and will hold a conference call to discuss the results on Thursday, August 6, 2026, at 1 p.m. Eastern/12 p.m. Central.
By Occidental · Via GlobeNewswire · July 1, 2026
If you purchased or acquired FS KKR Capital securities between May 8, 2024 and February 25, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
By Bragar Eagel & Squire · Via GlobeNewswire · July 1, 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sportradar (SRAD) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP / NHPAP / NHPBP) (the “Company”) announced today that its Board of Directors declared a quarterly dividend of $0.075 per share of its common stock (including its Class A Common Stock). The dividend will be payable in cash on July 30, 2026 to holders of record at the close of business on July 15, 2026.
By National Healthcare Properties · Via GlobeNewswire · July 1, 2026
SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the third quarter of 2026.
By Fate Therapeutics, Inc. · Via GlobeNewswire · July 1, 2026
Batesville, Ark., July 01, 2026 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a leading manufacturer of specialty chemicals and renewable biofuels, announced that it has finalized the sale of all its 2025 Section 45Z Clean Fuel Production and Small Producer Tax Credits to Freepoint Commodities (“Freepoint”). The credits stem from low-carbon biodiesel produced at the company’s Batesville facility.
By FutureFuel Corp. · Via GlobeNewswire · July 1, 2026
LONDON & GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus in accordance with Nasdaq Listing Rule 5635(c)(4).
By Autolus Therapeutics plc · Via GlobeNewswire · July 1, 2026
NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on June 30, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to one new employee, stock options to purchase an aggregate of 25,000 shares of the Company’s common stock, with a per share exercise price of $10.30.
By Candel Therapeutics · Via GlobeNewswire · July 1, 2026
SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), the leading provider of a unified real-time intelligence platform for casino resorts, today announced its participation in Raving's Casino Marketing & Technology Conference (CMTC) and Host & Player Development Conference, taking place July 14–16 at Pechanga Resort Casino in Temecula, California.
By QCI · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on July 1, 2026, the Company granted inducement awards to purchase up to 250,700 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · July 1, 2026
Sixty-four consecutive quarters of increased quarterly cash dividend on its common stock
By Bank OZK · Via GlobeNewswire · July 1, 2026
Company fully subscribed its inaugural Regulation A+ offering at the $25.7 million ceiling—nearly double the program average—requalified with the SEC and now reopens at an increased share price amid surging investor demand for energy technology
By Frontieras North America · Via GlobeNewswire · July 1, 2026
PASCAGOULA, Miss., July 01, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division began fabrication of the future USS John F. Lehman (DDG 137) Monday, marking the official start of construction on the Navy’s newest Flight III Arleigh Burke‑class destroyer.
By HII · Via GlobeNewswire · July 1, 2026
2,500 oz America 250 Silver Coin Certified During Official Ceremony in Austin, Texas
By Texas Precious Metals · Via GlobeNewswire · July 1, 2026
Long Beach, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Long Beach City College (LBCC) Athletics announced today a strategic reinvestment plan for the college’s baseball program tied to the future construction and modernization of the campus baseball complex. The area immediately south of Lew Davis Street is entering a period of significant transformation affecting multiple college operations, including student housing, baseball facilities, and future stadium and athletics complex renovations. These changes are part of a long-term investment strategy designed to modernize campus facilities and strengthen the future of LBCC Athletics, including the eventual return of baseball in a renewed and enhanced environment.
By Long Beach City College · Via GlobeNewswire · July 1, 2026
The Ph.D. program will highlight the interdisciplinary nature of the rapidly evolving field of cybersecurity, with artificial intelligence and other emerging technologies.
By Old Dominion University · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- D S Simon Media, a recognized innovator in broadcast public relations and AI search optimization, is celebrating its 40th anniversary on July 4th. "Obviously, a lot has changed during those 40 years, but what has stayed the same is the importance of discoverability for organizations and our ability to help them be found,” says founder and CEO Doug Simon.
By D S Simon · Via GlobeNewswire · July 1, 2026
By Bitget Limited · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- The American Kennel Club (AKC®), a not-for-profit organization that is the world’s largest registry of purebred and mixed-breed dogs, and a leading voice for canine welfare and responsible ownership, reminds dog owners the importance of keeping you and your pup cool in this heat.
By The American Kennel Club · Via GlobeNewswire · July 1, 2026
LONDON, July 01, 2026 (GLOBE NEWSWIRE) -- A PMOS diagnosis that finally made sense. The realisation that anxiety wasn't random after all. A conception journey that suddenly felt less overwhelming.
By Clue · Via GlobeNewswire · July 1, 2026
CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Today, Bizoforce is launching HeyAdmin.ai - an Agentic AI platform for Enterprises. Agentic AI autonomous workflows can be built on our platform and deployed on any platform at low cost through voice, video, and text agents.
By Bizoforce Inc. · Via GlobeNewswire · July 1, 2026
Los Angeles, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) (“Triller” or the “Company”) today provided an update regarding the capital raising flexibility approved by shareholders at the Company’s Annual Meeting held on June 10, 2026.
By Triller Group Inc. · Via GlobeNewswire · July 1, 2026
The carrier is celebrating its partnership with JGR while honoring service and community this Fourth of July.
By Saia, Inc. · Via GlobeNewswire · July 1, 2026
Novel allogeneic T-cell-based immunotherapy reduces chronic graft-versus-host disease (GVHD) in patients with blood cancers undergoing stem cell transplantation
By FDA · Via GlobeNewswire · July 1, 2026
Month-long Summit will Connect Entrepreneurs to Country’s Largest Source of Early-Stage Research and Development Funding
By U.S. Small Business Administration · Via GlobeNewswire · July 1, 2026
On-time delivery of Building 2 Phase 1 reinforces Applied Digital’s repeatable model for turning power into operational AI capacity
By Applied Digital Corporation · Via GlobeNewswire · July 1, 2026
Belmont, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Notre Dame de Namur University (NDNU) is proud to honor outgoing President Lizbeth J. Martin, PhD, as the recipient of the 2026 Indefatigable Award. Named for the ship that carried six Sisters of Notre Dame de Namur from Belgium to the United States in 1844, the annual award recognizes an individual whose life’s work reflects the Sisters’ enduring spirit of “unflagging, inexhaustible determination to make the world a better place.”
By Notre Dame de Namur University · Via GlobeNewswire · July 1, 2026
Second Consecutive MSP 501 Recognition Underscores Spectrotel's Continued Evolution in Delivering Intelligent, End-to-End Managed Network Services for Distributed Enterprises
By Spectrotel · Via GlobeNewswire · July 1, 2026
Company Moves From Filed IP Protection to Live Distribution, Positioning Digitalage for Initial Revenue Activation in the Creator Economy
By Digitalage · Via GlobeNewswire · July 1, 2026
UNION, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Kean University and New Jersey City University (NJCU) officials today completed a historic merger, establishing Kean Jersey City as the newest campus in the Kean system and expanding access to public higher education in New Jersey and beyond.
By Kean University · Via GlobeNewswire · July 1, 2026
New Solutions for Every Aviation Segment Launching in 2026Jeppesen ForeFlight Airflow™ Introduced as Company’s Aviation Intelligence Engine
By Jeppesen ForeFlight · Via GlobeNewswire · July 1, 2026
Funding supports local nonprofits advancing education, health, economic opportunity, and community well-being throughout the San Joaquin Valley
By The Wonderful Company · Via GlobeNewswire · July 1, 2026
Announcement establishes global hub for home improvement industry
By Do it Best · Via GlobeNewswire · July 1, 2026
Partnership brings elite athletic focus to INMOTION’s vision for clean, intuitive and joyful electric mobility
By INMOTION · Via GlobeNewswire · July 1, 2026
SCOTTSDALE, Ariz., July 01, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced an expanded strategic initiative focused on advancing the use of XWRAP® across surgical applications.
By Applied Biologics · Via GlobeNewswire · July 1, 2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) Although many people associate rice with savory dishes, this staple grain can actually level up your dessert game too. Cultures from around the world have invented a variety of creative ways to turn the sticky rice in your pantry into treats you can whip up when you’re on the prowl for something sweet.
By Feature Impact · Via GlobeNewswire · July 1, 2026
Orthopedic surgeon Dr. Scott Sigman and BEAR Implant patient and soccer coach Marcelo Cunha join YourUpdateTV to discuss ACL tears and the options for treating them
By D S Simon · Via GlobeNewswire · July 1, 2026
Firm expands leadership bench with key leadership additions and internal promotions as advisor platform continues rapid growth
By XYPN · Via GlobeNewswire · July 1, 2026
Safety leader brings more than 20 years of experience and focus on workforce development
By American Society of Safety Professionals · Via GlobeNewswire · July 1, 2026
SYDNEY, AUSTRALIA and NEW YORK, NY, July 01, 2026 (GLOBE NEWSWIRE) -- Btab Ecommerce Group, Inc. (OTC: BBTT) (“Btab”), a global ecommerce and technology company, today provided an update on its proposed business combination with Integrated Wellness Acquisition Corp. (OTC: WELNF) (“IWAC”), a publicly traded special purpose acquisition company, while defining its long-term corporate purpose ahead of its next stage of growth.
By Btab Ecommerce Group, Inc. · Via GlobeNewswire · July 1, 2026
Program delivers hands-on access to 40+ robotics companies, live demonstrations, and expert-led education to transform cleaning operations
By Informa Markets Infrastructure & Construction · Via GlobeNewswire · July 1, 2026
CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2,650,000 shares of its common stock for a total of $500,000 in the open market, at an average price of approximately $0.1887 per share.
By Cosmos Health Inc. · Via GlobeNewswire · July 1, 2026
Mixologist and BOMBAY SAPPHIRE Brand Ambassador, Eddy Johnson, Discusses the French Blonde, Tips for Making it at Home, and Why It’s the Cocktail to Watch this Wedding Season
By D S Simon · Via GlobeNewswire · July 1, 2026
